Emmes Acquires UK-Based Orphan Reach
Second Add-on Acquisition Under Behrman’s Ownership Further Expands Emmes’ European Footprint and Market-Leading Capabilities in Rare Diseases Rockville, MD, May 11, 2021 – Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public…